Clinical Oncology Pharmacists play a vital role in the care of cancer patients by managing the safe and effective use of anti-cancer medications. With deep expertise in oncology pharmacotherapy, they are responsible for preparing, dispensing, and monitoring complex drug regimens including chemotherapy, immunotherapy, targeted therapies, and supportive care drugs. These professionals ensure that medications are dosed accurately based on individual patient factors such as body weight, organ function, and potential drug interactions, reducing the risk of side effects and enhancing treatment effectiveness.
Oncology pharmacists work closely with oncologists, nurses, and other healthcare providers to design personalized treatment plans. They examine each patient’s medical history and treatment goals to recommend appropriate medications and adjust therapy as needed. One of their core responsibilities is to educate patients and caregivers—providing clear explanations of how medications work, what side effects to expect, and how to manage them. This education helps improve medication adherence and empowers patients to take an active role in their care. Clinical oncology pharmacists are also involved in quality improvement, clinical trials, and the development of treatment protocols. They contribute to research and help integrate new therapies into practice safely and effectively. Their role is essential not just in managing treatment, but also in ensuring safety, minimizing toxicity, and improving outcomes. By combining clinical precision with patient-centered care, clinical oncology pharmacists enhance the overall quality and success of cancer treatment.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China